Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

This Government Contract opportunity from Department Of Health And Human Services was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Floxuridine 500mg Vials for Injection

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424220
DIBBS
Pharmaceutical Supply and DistributionThe contract entails the procurement and delivery of one package of Morphine Sulfate Injection, identified by NSN 6505014830274 and NDC 00641612725, under strict adherence to federal pharmaceutical and logistics regulations. The shipment is designated FOB destination and must be delivered to a U.S. Navy vessel stationed at FPO AE 09570, ensuring compliance with military supply chain protocols and secure handling requirements for controlled substances. The transaction is classified as a subcontract under the NAICS code 424220 for Pharmaceutical and Pharmaceutical Bulk Product Merchant Wholesalers, managed by the Defense Logistics Agency on behalf of the Department of Defense. The opportunity was posted on July 16, 2026, and is accessible via the DIBBS portal with the contract identification SPE2DX25D9900 and delivery reference SPE2DP26F7723, reflecting its integration into the broader military medical supply infrastructure.
Defense Logistics Agency

POSTED

about 2 months ago

DEADLINE

N/A
NAICS: 424220
DIBBS
Pharmaceutical Supply – Ondansetron HydrochlorideThe contract requires the supply and delivery of two bottles of Ondansetron Hydrochloride, identified by NSN 6505015818923, to a U.S. Navy submarine outfitting site located in North Stonington, Connecticut. The transaction is governed by federal pharmaceutical distribution standards and must fully comply with all requirements set forth by the Defense Logistics Agency. The item is being procured under a subcontract linked to the primary contract SPE2DX25D8022, with delivery tracked under the logistics identifier SPE2D926F7413. The procurement falls under NAICS code 424220, which categorizes it within pharmaceutical and biological product wholesaling. The contract was posted on July 16, 2026, under the authority of the Department of Defense, with the Defense Logistics Agency as the overseeing agency, ensuring adherence to standardized military procurement protocols and supply chain integrity.
Defense Logistics Agency

POSTED

about 2 months ago

DEADLINE

N/A
NAICS: 424220
Federal
Reverse Osmosis Water System MaintenanceThe Department of the Navy is forecasting a contract for Reverse Osmosis Water System Maintenance to be performed at MCAS Cherry Point in Havelock, North Carolina. This requirement falls under NAICS code 424220 and was posted on July 2, 2026. The project focuses on the upkeep and operational maintenance of water purification systems at the specified military installation. Interested parties can find further information through the Secretary of the Navy small business portal.
Mcas Cherry Point, Havelock, Nc

POSTED

2 months ago

DEADLINE

N/A
NAICS: 424220
DIBBS
Supply of Doxycycline Hyclate Tablets (Generic Pharmaceutical)
Defense Logistics Agency

POSTED

2 months ago

DEADLINE

N/A
NAICS: 424220
DIBBS
Pharmaceutical Product Supply – Dexamethasone Sodium Phosphate Injection
Defense Logistics Agency

POSTED

2 months ago

DEADLINE

N/A
NAICS: 424220
DIBBS
Pharmaceutical Supply – FLUMAZENIL INJECTIONThe contract entails the supply and delivery of two packages of FLUMAZENIL INJECTION to a U.S. Navy vessel operating at a foreign port, with strict adherence to both Food and Drug Administration and Department of Defense standards to ensure pharmaceutical safety and compliance. The procurement is classified as a subcontract under the NAICS code 424220, indicating it falls within the pharmaceutical and bulk drug merchant wholesaling category, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. Execution requires precise coordination for international logistics, including regulatory compliance, secure transportation, and timely delivery to support military medical readiness in remote operational environments. The contract was posted on June 26, 2026, and is linked to the award record SPE2DX25D8022 with delivery identifier SPE2D926F6890, underscoring its formal placement within the DLA’s contractual framework.
Defense Logistics Agency

POSTED

3 months ago

DEADLINE

N/A

AI Contract Overview

Show more

The contract involves the procurement and delivery of 10 vials of Floxuridine 500mg for injection, USP, which must be FDA-approved and conform to specific National Drug Codes (NDC 0143-9270-01 or 81643-9270-1). This procurement is for a subcontract issued by the National Institutes of Health, part of the Department of Health and Human Services, and is designated under the NAICS code 424220, which pertains to pharmaceutical and drug merchant wholesalers. The solicitation for this contract was posted on May 20, 2026, with a response deadline of June 3, 2026, at 4:00 PM. The place of performance is Bethesda, Maryland, with the ZIP code 20892. While there is no set-aside type or further specification regarding organizational type, the contract emphasizes strict adherence to the product’s specificity requirements to ensure compliance and suitability for its intended medical use.

General Info

Procurement of 10 FDA-approved Floxuridine 500mg vials for NIH subcontract, delivery Bethesda, MD.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

424220

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

This scope was carved out of NOI-CC-OLAO-26-006059.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Intent to Sole Source - X10 VIALS of Floxuridine 500MG vials

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Procurement and delivery of 10 vials of FDA-approved Floxuridine 500mg for injection, USP, under strict product specificity (NDC 0143-9270-01 or 81643-9270-1).

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 811210
New
Federal
Notice of Intent to Award to a Single Source - Maintenance Service for Molecular Devices SpectraMax Paradigm Multi-Mode Microplate Readers - PCA-NIAID-09685
Solicitation # PCA-NIAID-09685
The National Institutes of Health National Institute of Allergy and Infectious Diseases intends to award a one-year firm-fixed-price contract to Molecular Devices for the maintenance of SpectraMax Paradigm Multi-Mode Microplate Readers. The services will be performed at the NIH Vaccine Immunology Program Lab in Gaithersburg, Maryland, and include a compliance assurance service plan, onsite performance assurance, onsite essential protection, and the replacement of consumable parts. This is a sole-source procurement based on the determination that using the proprietary factory service is necessary to maintain data integrity and control for ongoing research studies. While this is not a request for competitive quotations, interested parties may submit capability statements to James French by September 16, 2026, for consideration before a final award decision is made.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
Federal
Intent to Sole Source - a Preventative Maintenance Agreement (PMA) for the Alpha Omega Machine
Solicitation # NOI-OLAO-CC-26-010000
The National Institutes of Health Clinical Center intends to negotiate a sole source Preventative Maintenance Agreement for the Alpha Omega Machine, a specialized micro-electrode recording and stimulation system used in deep brain stimulation surgery. This equipment supports protocol 11-N-0211 by providing the Surgical Neurology Branch with capabilities for capturing single-unit spiking, local field potential, and surface EEG data, as well as real-time online analyses and electrical stimulation. The government has identified Alpha Omega as the only responsible source capable of satisfying these requirements under statutory authority 41 U.S.C. 253(c)(1). While this is a notice of intent rather than a request for proposal, interested sources may submit capability statements to the designated point of contact by September 21, 2026. The final determination regarding whether to compete the requirement remains at the discretion of the government.
Surgical and Medical Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 484220
New
Federal
Genomic Sample Logistics and Chain-of-Custody Management
Specialized Freight (except Used Goods) Trucking, Local

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541511
New
Federal
Bioinformatics Analysis and Variant Calling
Custom Computer Programming Services

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
New
Federal
Genomic Sequencing and Genotyping Laboratory Services
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
New
Federal
5-Base Whole Genome Sequencing & Multiomic Profiling Services
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541380
New
Federal
Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
Solicitation # NOI-PCA-NIDA-09054
The National Institutes of Health, under the Department of Health and Human Services, has issued a Notice of Intent for a contract titled Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder. This project, identified by solicitation number NOI-PCA-NIDA-09054, focuses on conducting pharmacogenomic research related to the use of semaglutide in treating alcohol use disorder. The work is categorized under NAICS code 541380 and will be performed in Baltimore, Maryland. The notice was posted on September 8, 2026, with a response deadline of September 15, 2026. There is no specific set-aside designated for this opportunity. Primary coordination for this effort is managed by Zachary Fetters, with Ashley Kinderdine serving as the secondary point of contact.
Testing Laboratories and Services

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541380
New
Federal
IDENTIFY Study Participants – 5-Base Sample Preparation and Whole Genome Multiomic Profiling
Solicitation # 75N98026Q01158
The National Institutes of Health, specifically the Prenatal Genomics and Therapy Section within the National Human Genome Research Institute, is seeking 5-base whole genome sequencing services for plasma-derived cell-free DNA samples from the IDENTIFY study. The project requires 5Base sample preparation and multiomic profiling at 30x coverage to generate high-resolution genomic and epigenomic data from women whose prenatal sequencing suggested maternal malignancy. The primary goal of this acquisition is to produce high-quality data to support computational models for determining the tissue source of incidentally detected maternal cancers. This effort aims to improve the interpretation of prenatal sequencing results, enhance early cancer detection during pregnancy, and advance the broader understanding of circulating cell-free DNA biology. The solicitation is identified as 75N98026Q01158 with a response deadline of September 15, 2026.
Testing Laboratories and Services

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
SBIR / STTR
Clinical Research & Data AnalysisThis subcontract for the National Institutes of Health under the Department of Health and Human Services focuses on clinical research and data analysis for National Cancer Institute projects. The selected provider will analyze human specimens and clinical data using bioinformatic software and statistical tools such as SAS, R, and Python to deliver comprehensive data analysis reports and clinical significance summaries. The opportunity is a total small business set-aside under NAICS code 541715, requiring the contractor to have fewer than 500 employees. Strict adherence to IRB approval and compliance with Appendix H.1 and H.2 regarding human subjects is mandatory. The response deadline for this solicitation is September 21, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 months ago

DEADLINE

in 8 days
View Details
NAICS: 541380
SBIR / STTR
Biomarker Qualification and Assay ServicesThis subcontract for Biomarker Qualification and Assay Services supports prime contractors on NIH National Cancer Institute projects. The selected provider will perform laboratory analysis to qualify biomarkers and develop performance metrics for diagnostic assays using mass spectrometers, PCR machines, and flow cytometers for the quantitative analysis of biological samples. All work must be conducted under GLP or CLIA/CAP certification, with the final deliverables consisting of qualification data and assay performance reports. The opportunity is a total small business set-aside under NAICS code 541380, specifically targeting firms with fewer than 500 employees in accordance with SBIR/STTR mandates. Managed by the Department of Health and Human Services for the NIH, the solicitation was posted on July 10, 2026, with a response deadline of September 21, 2026.
Testing Laboratories and Services

POSTED

2 months ago

DEADLINE

in 8 days
View Details
NAICS: 339113
SBIR / STTR
Medical Device/Technology PrototypingThis subcontract opportunity with the NIH Department of Health and Human Services focuses on the fabrication of physical prototypes and phantoms for innovative technology used in National Cancer Institute projects. The scope of work includes CAD design, 3D printing, precision machining, and electronic circuit fabrication, with a specific requirement for the use of biocompatible materials and the performance of safety assessments to deliver functional models for validation. The project is designated as a total small business set-aside under the SBIR/STTR mandate for companies with fewer than 500 employees, falling under NAICS code 339113. The solicitation was posted on July 10, 2026, with a response deadline of September 21, 2026.
Surgical Appliance and Supplies Manufacturing

POSTED

2 months ago

DEADLINE

in 8 days
View Details
NAICS: 541715
SBIR / STTR
In Vivo Validation ServicesThis subcontract for In Vivo Validation Services supports NIH National Cancer Institute projects by providing biological validation of technology using vertebrate animal models. The scope of work includes conducting in vivo studies, animal handling, dosing, and monitoring biological responses, culminating in a validation report featuring quantitative performance data. To ensure compliance with NIH Section 8.7, the provider must utilize AAALAC-accredited animal facilities and obtain all necessary IACUC approvals. The opportunity is a total small business set-aside under NAICS code 541715, specifically targeting firms with fewer than 500 employees in accordance with SBIR/STTR mandates. Interested parties must submit their responses by September 21, 2026, for this Department of Health and Human Services initiative.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 months ago

DEADLINE

in 8 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS